Friday, Apr 19 2024 | Time 19:07 Hrs(IST)
image
Business EconomyPosted at: Nov 13 2020 11:41PM


Kotak AMC's Pharma Portfolio delivers 42.3 per cent return over a year

Kolkata, Nov 13 (UNI) Kotak Mahindra Asset Management Company Limited’s (KMAMC) Portfolio Management Service division (Kotak PMS), today announced that it will share profits with investors generated from the Kotak Pharma and Healthcare (Kotak Pharma) portfolio. Pharma and healthcare stocks have become market darlings. This has been driven by market expectations of a likely shift in global Pharma supply chains away from China and toward India. Kotak Pharma and healthcare portfolio has been a direct beneficiary of this trend.

Kotak Pharma and Healthcare portfolio has registered 13 per cent returns over the past three years as compared to 4.8 per cent returns by Nifty Pharma and 4 per cent by Nifty 50 index. Since 20th September 2016, the inception date, the portfolio has generated returns of 9.2 per cent as compared to 7 per cent rise in Nifty 50 and negative (1.1 per cent) growth by Nifty Pharma.

As on 30th October 2020, Kotak Pharma and Healthcare strategy has delivered 42.3 per cent returns (net of all fees), over one year, effectively, outperforming the benchmark Nifty 50 by a wide margin, which has posted negative (-2 per cent) returns during the same period. The Nifty Pharma index performance is largely in-line, clocking a return of 42.7 per cent.

Anshul Saigal, Portfolio Manager and Head - PMS, Kotak Mahindra Asset Management Company said, “We are delighted to announce a Diwali bonanza to our PMS investors. Kotak Pharma & Healthcare PMS has outperformed on all relevant benchmarks by a handsome margin over the complete investment cycle (3-5 years). We cherry-picked stocks backed by strong fundamentals and invested at a time when the pharma was out of favour. Patience is indeed a virtue and it has helped us create wealth for our PMS investors.”

Investors have the option of deploying profits in whole or in part in the Kotak’s FinTech portfolio or even continue to stay invested i.e. retain profits in the Pharma & Healthcare portfolio to capture future potential upside.
UNI XC 2341
Please log in to get detailed story.
Tags: #Kotak AMC's Pharma Portfolio delivers 42.3 per cent return over a year
More News
Sensex recovers 600 points on heavy buying on last day of week

Sensex recovers 600 points on heavy buying on last day of week

19 Apr 2024 | 5:34 PM

Mumbai, April 19 (UNI) Snapping a losing streak of last four sessions, the BSE Sensex on Friday bounced back 599.34 points to close at 73088.33 on expectation of minimal escalation of tension between Israel and Iran.

see more..

19 Apr 2024 | 5:24 PM

Mumbai, Apr 19 (UNI) IT major Wipro on Friday reported 7.80% year-on-year dip in consolidated net profit at Rs 2,834.6 crore for January-March quarter (Q4) of the financial year 2023-24.

see more..
Rupee up 8 paise against USD

Rupee up 8 paise against USD

19 Apr 2024 | 5:05 PM

Mumbai, April 19 (UNI) The Rupee on Friday ended positive at 83.47, rising 8 paise against the USD on selling US Dollar by bankers and exporters, dealers at the Foreign exchange said.

see more..

Kottayam-Kochi Rubber Market rates

19 Apr 2024 | 5:02 PM

Kottayam, April 19 (UNI) Following were the Rubber Market rates announced by the Rubber Board here on Friday per quintal.

see more..
Sensex jumps 599 34 pts

Sensex jumps 599 34 pts

19 Apr 2024 | 4:56 PM

Mumbai, April 19 (UNI) Snapping a losing streak of last four sessions, the BSE Sensex on Friday bounced back 599.34 pts to close at 73088.33 on the strength of Bankex, Metal, Financial services and Consumer Durable stocks amid weak Asian Market.

see more..
image